Deep Gaussian process (DGP) models offer a powerful nonparametric approach for Bayesian inference, but exact inference is typically intractable, motivating the use of various approximations. However, existing approaches, such as mean-field Gaussian assumptions, limit the expressiveness and efficacy of DGP models, while stochastic approximation can be computationally expensive. To tackle these challenges, we introduce neural operator variational inference (NOVI) for DGPs. NOVI uses a neural generator to obtain a sampler and minimizes the regularized Stein discrepancy (RSD) between the generated distribution and true posterior in L space. We solve the minimax problem using Monte Carlo estimation and subsampling stochastic optimization techniques and demonstrate that the bias introduced by our method can be controlled by multiplying the Fisher divergence with a constant, which leads to robust error control and ensures the stability and precision of the algorithm. Our experiments on datasets ranging from hundreds to millions demonstrate the effectiveness and the faster convergence rate of the proposed method. We achieve a classification accuracy of 93.56 on the CIFAR10 dataset, outperforming state-of-the-art (SOTA) Gaussian process (GP) methods. We are optimistic that NOVI possesses the potential to enhance the performance of deep Bayesian nonparametric models and could have significant implications for various practical applications.

Download full-text PDF

Source
http://dx.doi.org/10.1109/TNNLS.2024.3406635DOI Listing

Publication Analysis

Top Keywords

neural operator
8
operator variational
8
variational inference
8
regularized stein
8
stein discrepancy
8
deep gaussian
8
gaussian process
8
dgp models
8
inference
4
inference based
4

Similar Publications

Background: Postoperative delirium (POD) is a common complication after major surgery and is associated with poor outcomes in older adults. Early identification of patients at high risk of POD can enable targeted prevention efforts. However, existing POD prediction models require inpatient data collected during the hospital stay, which delays predictions and limits scalability.

View Article and Find Full Text PDF

Neuroplasticity in Diffuse Low-grade Gliomas: Backward Modelling of Brain-tumor Interactions Prior to Diagnosis is Needed to Better Predict Recovery after Treatment.

Curr Neurol Neurosci Rep

January 2025

Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, 80 Avenue Augustin Fliche, Montpellier, 34295, France.

Purpose Of Review: In low-grade glioma (LGG), besides the patient's neurological status and tumor characteristics on neuroimaging, current treatment guidelines mainly rely on the glioma's genetics at diagnosis to define therapeutic strategy, usually starting with surgical resection. However, this snapshot in time does not take into account the antecedent period of tumor progression and its interactions with the brain before presentation. This article reviews new concepts that pertain to reconstruct the history of previous interplay between the LGG's course and adaptive changes in the connectome within which the glioma is embedded over the years preceding the diagnosis.

View Article and Find Full Text PDF

Automated diagnosis and classification of metacarpal and phalangeal fractures using a convolutional neural network: a retrospective data analysis study.

Acta Orthop

January 2025

Department of Orthopaedic Surgery, Danderyd Hospital, Stockholm; 2 Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.

Background And Purpose:  Hand fractures are commonly presented in emergency departments, yet diagnostic errors persist, leading to potential complications. The use of artificial intelligence (AI) in fracture detection has shown promise, but research focusing on hand metacarpal and phalangeal fractures remains limited. We aimed to train and evaluate a convolutional neural network (CNN) model to diagnose metacarpal and phalangeal fractures using plain radiographs according to the AO/OTA classification system and custom classifiers.

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

Columbia University Irving Medical Center, New York, NY, USA.

Background: This talk will review the Framework and discuss how it can be used to help conceive of and design research studies into cognitive reserve, brain maintenance and brain reserve. It will also highlight several funded pilot awards that emerged to implement the operational definitions. Finally, the talk will highlight the fourth Collaboratory workshop at which a set of collaborative research projects were initiated that make use of the Framework and address both human and nonhuman cognition.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Background: As new treatments (such as the anti-amyloid vaccine, lecanamab) emerge for Alzheimer's disease (AD) and other dementias, approaches are required to rapidly diagnose AD at the earliest possible stage, and to assess disease progression and prognosis. In January 2024, the FDA approved the first AI tool to predict AD progression based on magnetic resonance imaging (MRI) [1]. Here we train a generative AI approach based on latent diffusion models - to encode disease effects on brain structures.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!